Cooper Companies Inc (COO): Allan E Rubenstein , director of Cooper Companies Inc sold 2,150 shares on Jun 23, 2016. The Insider selling transaction was reported by the company on Jun 23, 2016 to the Securities and Exchange Commission. The shares were sold at $165.63 per share for a total value of $356,104.50 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 22, 2016, Allan E Rubenstein (director) sold 2,000 shares at $166.00 per share price.On Jun 22, 2016, Jody S Lindell (director) sold 5,000 shares at $165.00 per share price.Also, On Jun 22, 2016, A Thomas Bender (director) sold 5,400 shares at $165.09 per share price.On Jun 15, 2016, Gary S Petersmeyer (director) sold 3,000 shares at $162.51 per share price.
Cooper Companies Inc: On Tuesday, Jun 21, 2016 heightened volatility was witnessed in Cooper Companies Inc which led to swings in the share price. The shares opened for trading at $165 and hit $166.65 on the upside , eventually ending the session at $165.56, with a gain of 0.78% or 1.28 points. The heightened volatility saw the trading volume jump to 4,22,543 shares. The 52-week high of the share price is $181.01 and the company has a market cap of $8,021 M . The 52-week low of the share price is at $119.28.
Company has been under the radar of several Street Analysts.Cooper Companies Inc is Reiterated by Jefferies to Buy and the brokerage firm has raised the Price Target to $ 190 from a previous price target of $175 .The Rating was issued on Jun 3, 2016.Cooper Companies Inc is Upgraded by Jefferies to Buy. Earlier the firm had a rating of Hold on the company shares. The Rating was issued on Apr 15, 2016.
The Cooper Companies Inc. (Cooper) is a global medical device company. The Company operates through two business units CooperVision Inc. (CVI) and CooperSurgical Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women’s health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital Office and Fertility Clinic. CooperVision develops manufactures and markets a range of monthly two-week and single-use contact lenses featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism presbyopia and ocular dryness and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch SeeClear and Mobius.